Deferred Tax Assets, Operating Loss Carryforwards of LAVA Therapeutics NV from 31 Dec 2023 to 31 Dec 2024
Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
LAVA Therapeutics NV quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Dec 2023 to 31 Dec 2024.
LAVA Therapeutics NV Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2024 was $27,967,000, a 52% increase year-over-year.
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.